Knowledge Base

As a leading CDMO that specialises in complex dosage form design, formulation and manufacture for clinical trials, learn about our current thinking within the industry sector

PY 1/16/25 PY 1/16/25

Enhancing the intranasal delivery of mRNA therapeutics using a novel thermosensitive polymer

PY 1/14/25 PY 1/14/25

Development and evaluation of nebulised oligonucleotide formulations for the treatment of chronic obstructive pulmonary disease.

PY 8/28/24 PY 8/28/24

Read Ab Initio & Oz-UK’s recent article highlighting advanced tools that we can use to ease MDI product development

PY 5/23/24 PY 5/23/24

Respiratory Product Development and GMP Manufacturing Services

PY 5/14/24 PY 5/14/24

Clinical Trial Support Services: Focus on GMP

PY 5/2/24 PY 5/2/24

Streamlined MDI Development Partnership

PY 5/1/24 PY 5/1/24

Revolutionising Nasal Product Development and Manufacturing

PY 4/30/24 PY 4/30/24

Why choose Australia as your CDMO

PY 4/2/24 PY 4/2/24

Do you know what is in your trial medicine?

PY 3/1/24 PY 3/1/24

Meeting Challenges in Inhaled Drug Delivery

PY 2/29/24 PY 2/29/24

Preclinical Tools for early phase formulation development

PY 1/1/24 PY 1/1/24

Ab Initio Services Overview